The aim of the TCAM service is to improve the post-discharge support for patients by facilitating early medicine reconciliation, thereby reducing re-admissions/emergency department attendances and reduce errors on medication prescribed and supplied in the community following changes instigated in hospital.
Through the national implementation of TCAM in 2018-2020, each AHSN will support their local trusts to establish a TCAM pathway. This will enable all suitable patients to be referred to their community pharmacy or GP pharmacist where appropriate.
AHSNs have high level targets to improve the number of hospitals and discharges implementing TCAM referrals. Nationally, with rapid adoption across all 15 AHSNs, TCAM has the potential to save £13.8 million, reduce length of stay by 56,704 days and achieve 1,004 fewer readmissions in 2018-19. In 2019-20, savings of £28.8 million are projected, based on a reduction in length of stay of 113,406 days and 2,007 fewer re-admissions.